Only one published report has described KRAS mutations in SCCHN to date, and in this analysis of 29 oral squamous cell carcinoma tumors, 9 (6.9%) were found to harbor KRAS mutations [24]. This evidence concerns the gene KRAS and head and neck squamous cell carcinoma.